Self-enhancing immunomodulatory nanocomposite hydrogel platform integrates potent ICD induction and immunosuppression reversal for triple-negative breast cancer therapy
Chinese Chemical Letters · 2026-05 · 112931
DOI: 10.1016/j.cclet.2026.112931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-05. Verfasst von Xinlong Wang und 6 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Shenyang Key Laboratory of Functional Drug Carrier Materials.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Shenyang Key Laboratory of Functional Drug Carrier Materials
Zitieren
APA
Wang, X., Cai, Y., Yang, Z., Li, H., Deng, J., Zheng, J., & Yuan, Y. (2026). Self-enhancing immunomodulatory nanocomposite hydrogel platform integrates potent ICD induction and immunosuppression reversal for triple-negative breast cancer therapy. Chinese Chemical Letters, 112931. https://doi.org/10.1016/j.cclet.2026.112931
Vancouver
Wang X, Cai Y, Yang Z, Li H, Deng J, Zheng J, et al. Self-enhancing immunomodulatory nanocomposite hydrogel platform integrates potent ICD induction and immunosuppression reversal for triple-negative breast cancer therapy. Chinese Chemical Letters. 2026:112931. doi:10.1016/j.cclet.2026.112931
BibTeX
@article{Wang2026,
author = {Wang, Xinlong and Cai, Yang and Yang, Zhaofei and Li, Hui and Deng, Jinyu and Zheng, Jiani and Yuan, Yue},
title = {Self-enhancing immunomodulatory nanocomposite hydrogel platform integrates potent ICD induction and immunosuppression reversal for triple-negative breast cancer therapy},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {112931},
doi = {10.1016/j.cclet.2026.112931}
}
EUVIMED